StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.13−0.02 (-11.11%)

Close on Nov 19, 2026Market cap $5.87MP/E –Yield –

Theriva Biologics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Theriva Biologics's price to book ratio was 0.3× on Jan 31, 2023, against 0.7× a year earlier. Over the last 5 years it ranged from 0.1× to 68.4×, with a median of 3.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 20230.3×+0.1
2022Dec 30, 20220.1×−0.4
2021Dec 31, 20210.5×−2.7
2020Apr 30, 20203.2×+1.5
2019Dec 31, 20191.7×−20.1
2017Oct 31, 201721.8×−33.9
2016Oct 31, 201655.7×+47.7
2015Dec 31, 20158.0×−14.7
2014Dec 31, 201422.7×+12.0
2013Dec 31, 201310.7×+2.2
2012Dec 31, 20128.6×+4.3
2011Dec 30, 20114.2×–

More Theriva Biologics figures

See a number that looks wrong?